Boston An independent LDT provider

Genetic Risk Assessment and Screening for Pancreatic Cancer webinar

December 8, 2021

Intended for gastroenterologists and genetic counselors, this webinar took place on November 9, 2021, for members of the Collaborative Group of the Americas Inherited Gastrointestinal Cancer (CGA-IGC).

Presented by:
Fay Kastrinos, MD, MPH
Associate Professor of Medicine
Columbia University Irving Medical Center
Division of Digestive and Liver Diseases
Herbert Irving Comprehensive Cancer Center
New York-Presbyterian/Columbia University
New York, NY

Thomas C. King, MD, PhD
Medical Director
Immunovia, Inc.
Marlborough, MA

Dr. Fay Kastrinos is a gastroenterologist with special expertise in genetic risk stratification for the early detection and prevention of gastrointestinal cancers, notably colorectal cancer and pancreatic cancer. She has led clinical studies aimed at screening and the early detection of these cancers and in the development of clinical risk assessment tools for routine use by healthcare providers. Dr. Kastrinos’ collaborative research studies also span to the evaluation of novel biomarkers for early cancer detection as well as innovative cancer prevention modalities. Dr. Fay Kastrinos serves as the Director of the Gastrointestinal Cancer High Risk and Prevention Clinic and the Muzzi Mirza Pancreatic Cancer Prevention and Genetics Program at Columbia University’s Herbert Irving Comprehensive Cancer Center.

Following Dr. Kastrinos’ presentation, Dr. Thomas King presents recent data about the IMMray® PanCan-d test in individuals at high risk for developing familial or hereditary pancreatic ductal adenocarcinoma. The presentations are followed by a live question and answer session.